Ocuphire Pharma OCUP
$ 1.17
-12.03%
Quarterly report 2024-Q3
added 11-12-2024
Country |
USA |
IPO year |
- |
Industry |
- |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
- |
Employees in the company |
- |
Shares |
21.6 M |
Market Cap[1] |
$ 25.3 M |
EBITDA (LTM) |
$ -9.67 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.